Abstract
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (PLGANPs) have been widely investigated for sustained and targeted delivery of various drugs including small molecular drugs (hydrophobic/ hydrophilic drugs) and macromolecule drugs (such as proteins, peptides, genes, vaccines, antigens, human growth factors, etc.). The in vivo pharmacokinetics and disposition profile of these encapsulated drugs and PLGANPs themselves is a key factor that determines their therapeutic index and potential for clinical use. Therefore, this review attempts to outline the in vivo behaviors of diverse drugs loaded PLGANPs administrated via different routes such as oral route, intravenous injection, nasal path, etc. . Also, the associated analytical techniques used to investigate the in vivo disposition of PLGANPs loaded with drugs are focused on.
Keywords: Analytical technique, disposition, distribution, in vivo behavior, nanoparticles, PLGA, pharmacokinetics, Polylactic-co-glycolic acid, biocompatible polymers, hydrophobic drugs, hydrophilic drugs, paclitaxel, hepatotoxicity, Tmx-NPs, Toxoplasma
Current Drug Metabolism
Title: Pharmacokinetics and Disposition of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (PLGA) Nanoparticles
Volume: 11 Issue: 10
Author(s): Xiangrong Song, Xia Zhao, Yan Zhou, Shuangzhi Li and Qing Ma
Affiliation:
Keywords: Analytical technique, disposition, distribution, in vivo behavior, nanoparticles, PLGA, pharmacokinetics, Polylactic-co-glycolic acid, biocompatible polymers, hydrophobic drugs, hydrophilic drugs, paclitaxel, hepatotoxicity, Tmx-NPs, Toxoplasma
Abstract: Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (PLGANPs) have been widely investigated for sustained and targeted delivery of various drugs including small molecular drugs (hydrophobic/ hydrophilic drugs) and macromolecule drugs (such as proteins, peptides, genes, vaccines, antigens, human growth factors, etc.). The in vivo pharmacokinetics and disposition profile of these encapsulated drugs and PLGANPs themselves is a key factor that determines their therapeutic index and potential for clinical use. Therefore, this review attempts to outline the in vivo behaviors of diverse drugs loaded PLGANPs administrated via different routes such as oral route, intravenous injection, nasal path, etc. . Also, the associated analytical techniques used to investigate the in vivo disposition of PLGANPs loaded with drugs are focused on.
Export Options
About this article
Cite this article as:
Song Xiangrong, Zhao Xia, Zhou Yan, Li Shuangzhi and Ma Qing, Pharmacokinetics and Disposition of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (PLGA) Nanoparticles, Current Drug Metabolism 2010; 11 (10) . https://dx.doi.org/10.2174/138920010794479682
DOI https://dx.doi.org/10.2174/138920010794479682 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Production of Orally Applicable New Drug or Drug Combinations from Natural Origin Capsaicinoids for Human Medical Therapy
Current Pharmaceutical Design PPARs as Drug Targets to Modulate Inflammatory Responses?
Current Drug Targets - Inflammation & Allergy Licochalcone B Arrests Cell Cycle Progression and Induces Apoptosis in Human Breast Cancer MCF-7 Cells
Recent Patents on Anti-Cancer Drug Discovery Flavonoids: A Review of Its Commercial Application Potential as Anti- Infective Agents
Current Medicinal Chemistry - Anti-Infective Agents Obesity: Current Treatment and Future Horizons
Mini-Reviews in Medicinal Chemistry Editorial
Current Medical Imaging An Overview on Keratinocyte Growth Factor: From the Molecular Properties to Clinical Applications
Protein & Peptide Letters Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Meet Our Section Editor
Reviews on Recent Clinical Trials Ribosomal Proteins and Colorectal Cancer
Current Genomics Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry RecQ Family Helicases in Replication Fork Remodeling and Repair: Opening New Avenues towards the Identification of Potential Targets for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Graphical Abstracts
Current Drug Delivery Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal The Complex Biology of FOXO
Current Drug Targets Antibody Engineering, Virus Retargeting and Cellular Immunotherapy: One Ring to Rule Them All?
Current Gene Therapy Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors
Current Drug Delivery Stereoselective Pharmacodynamics and Pharmacokinetics of Proton Pump Inhibitors
Current Drug Metabolism Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Combined Modality Therapy in Pancreatic Adenocarcinoma: Review and Updates on a Controversial Issue
Current Pharmaceutical Design